Stockscreener 앱 받기
34.93
6.04%
1.99
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Collegium Pharmaceutical (COLL) Is Up 16.2% After Raising 2025 Revenue Guidance on Strong Q2 Results - simplywall.st
Collegium Pharmaceutical's Q2 2025: Key Contradictions on Jornay PM Sales Estimates and Pain Portfolio Competition - AInvest
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
Collegium Pharmaceutical Reports Record Q2 2025 Revenue, Raises Outlook and Initiates $150M Share Repurchase Program - AInvest
Why Collegium Pharmaceutical (COLL) Rose 10.3% After Raising 2025 Revenue Guidance Despite Lower Earnings - simplywall.st
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2025 Earnings Call Transcript - Insider Monkey
Collegium Pharmaceutical: Q2 Earnings Snapshot - Greenwich Time
Collegium Pharmaceutical Reports Strong Q2 2025 Results - TipRanks
Collegium Pharmaceuticals Reports Strong Earnings and Growth - TipRanks
Collegium Pharmaceutical’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
Truist Securities raises Collegium Pharmaceutical stock price target to $45 By Investing.com - Investing.com UK
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q2 Expectations, Stock Jumps 10.2% - FinancialContent
Collegium raises 2025 revenue guidance to $760M as Jornay PM growth accelerates - MSN
Collegium Pharmaceutical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Collegium Pharmaceutical Q2 2025 slides: Revenue surges 29%, guidance raised - Investing.com
Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates - sharewise.com
Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
SIXS ETF Implied Analyst Target Price: $58.24 - AInvest
Collegium Pharmaceutical Reports Record Q2 2025 Revenue - TipRanks
Collegium Pharmaceutical earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Reports Q2 Revenue $188.0M, vs. FactSet Est of $180.9M - MarketScreener
Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Posts Q2 Adjusted EPS $1.68 per Share, vs. FactSet Est of $1.62 - MarketScreener
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook - GlobeNewswire
Collegium Pharmaceutical Q2 Earnings: Revenue Expected to Grow 24.2% YoY - AInvest
Collegium Pharmaceutical (COLL) Q2 Earnings: What To Expect - Yahoo Finance
Collegium Pharmaceutical is helping individuals with ADHD - KOIN.com
Collegium Pharmaceuticals is helping those with ADHD - KOIN.com
Moving Average Crossover Confirms Uptrend in Collegium Pharmaceutical Inc.Breakout Momentum Picks With Protection Outlined - metal.it
Collegium Pharmaceutical Inc. Rebound Backed by Sentiment ShiftLow Risk High Return Opportunities Identified - metal.it
Real Time Chart Alerts Flash Bullish on Collegium Pharmaceutical Inc.Trade Ready Stock Watch for Short Term Published - metal.it
When is Collegium Pharmaceutical Inc. stock expected to show significant growthInvest smarter with comprehensive market analysis - Jammu Links News
Does Collegium Pharmaceutical Inc. stock perform well during market downturnsCapitalize on high-yield stocks early - Jammu Links News
Is Collegium Pharmaceutical Inc. stock overvalued or undervaluedGet insider insights into market trends - Jammu Links News
What is the risk reward ratio of investing in Collegium Pharmaceutical Inc. stockUnlock powerful stock screening for profits - Jammu Links News
What catalysts could drive Collegium Pharmaceutical Inc. stock higher in 2025Capitalize on market momentum for profits - Jammu Links News
What are Collegium Pharmaceutical Inc. company’s key revenue driversAccess powerful market insights for free - Jammu Links News
Is Collegium Pharmaceutical Inc. a good long term investmentAchieve consistent profits with proven methods - Jammu Links News
How does Collegium Pharmaceutical Inc. compare to its industry peersMaximize gains with professional stock picks - Jammu Links News
How many analysts rate Collegium Pharmaceutical Inc. as a “Buy”Invest in stocks with long-term growth potential - Jammu Links News
Collegium Pharmaceutical Inc. Stock Analysis and ForecastAchieve superior capital gains with smart trades - Jammu Links News
Collegium Pharmaceutical to report Q2 2025 financial results on August 7, 2025. - AInvest
What are the technical indicators suggesting about Collegium Pharmaceutical Inc.Real Time Tracker With High Returns - Jammu Links News
Back to School advice to help kids with ADHD Thrive| Talk of Alabama | 8.1.2025 - WBMA
0.43%
0.47%
자본화:
|
볼륨(24시간):